EVA
ALLONCA CAMPA
Investigador/a
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (9)
2023
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications, Vol. 14, Núm. 1
2020
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
2019
-
PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma
Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554
-
SOX2 expression is an independent predictor of oral cancer progression
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma
Cancers, Vol. 11, Núm. 11
-
The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders
Journal of Clinical Medicine, Vol. 8, Núm. 9